Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1969 1
1970 1
1971 2
1972 1
1973 3
1974 4
1975 5
1976 4
1977 5
1978 2
1979 2
1980 2
1981 1
1982 5
1983 2
1984 3
1985 3
1986 5
1987 2
1988 5
1989 2
1990 8
1991 4
1992 7
1993 6
1994 5
1995 5
1996 8
1997 9
1998 3
1999 8
2000 5
2001 5
2002 9
2003 9
2004 5
2005 12
2006 15
2007 7
2008 10
2009 8
2010 8
2011 5
2012 1
2013 2
2014 3
2015 5
2016 3
2017 1
2019 1
2020 3
2021 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Results by year

Filters applied: . Clear all
Page 1
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.
Cortes J, O'Shaughnessy J, Loesch D, Blum JL, Vahdat LT, Petrakova K, Chollet P, Manikas A, Diéras V, Delozier T, Vladimirov V, Cardoso F, Koh H, Bougnoux P, Dutcus CE, Seegobin S, Mir D, Meneses N, Wanders J, Twelves C; EMBRACE (Eisai Metastatic Breast Cancer Study Assessing Physician's Choice Versus E7389) investigators. Cortes J, et al. Among authors: chollet p. Lancet. 2011 Mar 12;377(9769):914-23. doi: 10.1016/S0140-6736(11)60070-6. Epub 2011 Mar 2. Lancet. 2011. PMID: 21376385 Clinical Trial.
[Adjuvant medical treatment].
Plagne R, Chollet P, Legros M, Cure H, Ferrière JP, Bignon YJ. Plagne R, et al. Among authors: chollet p. Rev Prat. 1990 Apr 1;40(10):905-8. Rev Prat. 1990. PMID: 2183339 Review. French.
Oral florid papillomatosis.
Collangettes D, Chollet P, Fonck Y. Collangettes D, et al. Among authors: chollet p. Eur J Cancer B Oral Oncol. 1993 Jan;29B(1):81-2. doi: 10.1016/0964-1955(93)90015-7. Eur J Cancer B Oral Oncol. 1993. PMID: 8180581
Methionine dependency and cancer treatment.
Cellarier E, Durando X, Vasson MP, Farges MC, Demiden A, Maurizis JC, Madelmont JC, Chollet P. Cellarier E, et al. Among authors: chollet p. Cancer Treat Rev. 2003 Dec;29(6):489-99. doi: 10.1016/s0305-7372(03)00118-x. Cancer Treat Rev. 2003. PMID: 14585259 Review.
[Digestive oncology: surgical practices].
Slim K, Blay JY, Brouquet A, Chatelain D, Comy M, Delpero JR, Denet C, Elias D, Fléjou JF, Fourquier P, Fuks D, Glehen O, Karoui M, Kohneh-Shahri N, Lesurtel M, Mariette C, Mauvais F, Nicolet J, Perniceni T, Piessen G, Regimbeau JM, Rouanet P, sauvanet A, Schmitt G, Vons C, Lasser P, Belghiti J, Berdah S, Champault G, Chiche L, Chipponi J, Chollet P, De Baère T, Déchelotte P, Garcier JM, Gayet B, Gouillat C, Kianmanesh R, Laurent C, Meyer C, Millat B, Msika S, Nordlinger B, Paraf F, Partensky C, Peschaud F, Pocard M, Sastre B, Scoazec JY, Scotté M, Triboulet JP, Trillaud H, Valleur P. Slim K, et al. Among authors: chollet p. J Chir (Paris). 2009 May;146 Suppl 2:S11-80. doi: 10.1016/S0021-7697(09)72398-1. J Chir (Paris). 2009. PMID: 19435621 Review. French. No abstract available.
[Therapeutic potential of melatonin in cancer treatment].
Abrial C, Kwiatkowski F, Chevrier R, Gachon F, Curé H, Chollet P. Abrial C, et al. Among authors: chollet p. Pathol Biol (Paris). 2005 Jun;53(5):265-8. doi: 10.1016/j.patbio.2004.12.009. Epub 2005 Jan 20. Pathol Biol (Paris). 2005. PMID: 15939135 Review. French.
[Stress, cancer and circadian rhythm of melatonin].
Kwiatkowski F, Abrial C, Gachon F, Chevrier R, Curé H, Chollet P. Kwiatkowski F, et al. Among authors: chollet p. Pathol Biol (Paris). 2005 Jun;53(5):269-72. doi: 10.1016/j.patbio.2004.12.018. Epub 2005 Jan 20. Pathol Biol (Paris). 2005. PMID: 15939136 Review. French.
Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?
Wang-Lopez Q, Chalabi N, Abrial C, Radosevic-Robin N, Durando X, Mouret-Reynier MA, Benmammar KE, Kullab S, Bahadoor M, Chollet P, Penault-Llorca F, Nabholtz JM. Wang-Lopez Q, et al. Among authors: chollet p. Crit Rev Oncol Hematol. 2015 Jul;95(1):88-104. doi: 10.1016/j.critrevonc.2015.02.011. Epub 2015 Mar 4. Crit Rev Oncol Hematol. 2015. PMID: 25900915 Review.
Neoadjuvant endocrine therapy in breast cancer.
Abrial C, Mouret-Reynier MA, Curé H, Feillel V, Leheurteur M, Lemery S, Le Bouëdec G, Durando X, Dauplat J, Chollet P. Abrial C, et al. Among authors: chollet p. Breast. 2006 Feb;15(1):9-19. doi: 10.1016/j.breast.2005.07.009. Epub 2005 Oct 17. Breast. 2006. PMID: 16230013 Review.
234 results